# Coconut Oil Cognition Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/coconut-oil-cognition-meta-analysis-evidence-review
Category: evidence-review
Summary: Coconut Oil Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are sys
Last reviewed: 2026-07-29
Reviewed by: Migaku Evidence Review
# Coconut Oil Cognition Meta-analysis: What the Evidence Says

## Quick Answer

Coconut Oil Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis | systematic review | 1 | 2026-04-15 | 10.3389/fnut.2026.1802531 |
| Foods to Prevent Cardiometabolic Disease: Moving from “Saturated Fat” to “Whole Foods” | preclinical study | 4 | 2026-06-01 | 10.1016/j.cdnut.2026.107717 |

## What The Sources Report

- In addition to the reduced quality of life and wellbeing for the patient, ADRD also imposes a cost on society through the significant financial burden of patient care. [Bonnechère Bruno (2026); evidence level 1]
- Diet is crucial in preventing cardiometabolic diseases (CMD), defined as obesity, type 2 diabetes (T2D), and cardiovascular disease (CVD), which now more broadly includes chronic kidney disease and metabolic dysfunction-associated steatotic liver disease. [Astrup Arne (2026); evidence level 4]
- Since 1980, an expanding body of evidence has raised questions about the validity of the original observations underpinning the diet-heart hypothesis. [Astrup Arne (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For coconut oil cognition meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Bonnechère Bruno (2026). The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis. DOI: 10.3389/fnut.2026.1802531. PMCID: PMC13127162. PMID: 42063954. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13127162/
- Astrup Arne (2026). Foods to Prevent Cardiometabolic Disease: Moving from “Saturated Fat” to “Whole Foods”. DOI: 10.1016/j.cdnut.2026.107717. PMCID: PMC13267541. PMID: 42305911. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13267541/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.